Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP570392.RAXxAResY9G6YqaFzJE4h5CZ9jFHWgB14jLD5Y91MtrlM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP570392.RAXxAResY9G6YqaFzJE4h5CZ9jFHWgB14jLD5Y91MtrlM130_assertion type Assertion NP570392.RAXxAResY9G6YqaFzJE4h5CZ9jFHWgB14jLD5Y91MtrlM130_head.
- NP570392.RAXxAResY9G6YqaFzJE4h5CZ9jFHWgB14jLD5Y91MtrlM130_assertion description "[The present study revealed that plasma concentration of PAX, 5-HTTLPR genotype, -1019C/G 5-HT(1A) genotype, PAS score at baseline, and adverse effects may influence the therapeutic response to PAX in patients with PD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP570392.RAXxAResY9G6YqaFzJE4h5CZ9jFHWgB14jLD5Y91MtrlM130_provenance.
- NP570392.RAXxAResY9G6YqaFzJE4h5CZ9jFHWgB14jLD5Y91MtrlM130_assertion evidence source_evidence_literature NP570392.RAXxAResY9G6YqaFzJE4h5CZ9jFHWgB14jLD5Y91MtrlM130_provenance.
- NP570392.RAXxAResY9G6YqaFzJE4h5CZ9jFHWgB14jLD5Y91MtrlM130_assertion SIO_000772 21688171 NP570392.RAXxAResY9G6YqaFzJE4h5CZ9jFHWgB14jLD5Y91MtrlM130_provenance.
- NP570392.RAXxAResY9G6YqaFzJE4h5CZ9jFHWgB14jLD5Y91MtrlM130_assertion wasDerivedFrom befree-20140225 NP570392.RAXxAResY9G6YqaFzJE4h5CZ9jFHWgB14jLD5Y91MtrlM130_provenance.
- NP570392.RAXxAResY9G6YqaFzJE4h5CZ9jFHWgB14jLD5Y91MtrlM130_assertion wasGeneratedBy ECO_0000203 NP570392.RAXxAResY9G6YqaFzJE4h5CZ9jFHWgB14jLD5Y91MtrlM130_provenance.